Webinars & Videos

CVRx banner

Integrating Barostim into a Comprehensive Heart Failure Program: How Duke Is Improving Outcomes & Navigating Reimbursement Challenges

Sponsored by CVRx

Duke University Health System has integrated Barostim into its comprehensive heart failure program. For patients with heart failure with reduced ejection fraction (HFrEF), Barostim is a device therapy that works with drug therapies to target the neurohormonal pathways responsible for heart failure progression and symptoms. Listen in as an advanced heart failure specialist discusses patient selection and post-implant management, the implant procedure, patient care pathways, and how Duke has incorporated Barostim into their system. 

Michael Reardon, MD, explained the low-risk Evolut 5-year results of TAVR vs. SAVR at ACC 2025. #ACC #ACC25 #ACC2025

5-year Evolut Low Risk Data: Durable clinical outcomes, outstanding valve performance

Sponsored by Medtronic

The late-breaking five-year results of the Evolut Low-Risk Trial presented at the American College of Cardiology (ACC) 2025 meeting in late March, showed positive results for the Evolut transcatheter aortic valve replacement (TAVR) system vs. surgical aortic valve replacement (SAVR). 

CAD in Women Webinar

Challenges of Diagnosing CAD in Women

Sponsored by Heartflow

Diagnosing female patients with coronary artery disease (CAD) has many challenges. Join us to hear from three key opinion leaders as they present data and new case studies demonstrating these difficulties, and the guidelines and pathways that help with diagnosis and management of women with suspected CAD.

Biosense Electrophysiology

Electrophysiology Innovation at Texas Cardiac Arrhythmia Institute

Sponsored by Johnson & Johnson MedTech

Most advancements in electrophysiology technology are small and incremental, but the experts at Texas Cardiac Arrhythmia Institute in Austin, TX, were quick to see distinct advantages when they started using the latest iteration of radio frequency ablation, the QDOT MICRO™ Catheter.

Howard Herrmann, MD, University of Pennsylvania, explains details of the SMART Trial 2-year results at CRT 2025, where Evolut performed better hemodynamically than the Sapien 3 TAVR valve in small annuli patients. The study included 87% women.

SMART 2-year TAVR hemodynamic data: Medtronic Evolut is better compared to Edwards Sapien in small annulus patients

Sponsored by Medtronic

Howard Herrmann, MD,  MSCAI, Hospital of the University of Pennsylvania, and lead invesigator for the SMART trial, explains details on the 2-year data comparing the Evolut vs. Sapien 3 for TAVR in small annulus patients.

Wellstar CCTA Webinar

Wellstar's CCTA + Heartflow Program Impact: Improving Patient Care While Driving Financial Growth

Sponsored by Heartflow

If you’re looking to grow your CCTA program or start one, listen in. Learn from cardiology and radiology experts at Wellstar Health System who have built a successful CCTA program.

Nicholas Galante

AI is revolutionizing radiology workflow and patient care

Sponsored by Viz.ai

In the rapidly evolving healthcare landscape, artificial intelligence (AI) is making significant strides in improving radiology workflow and patient care coordination. Nicholas Galante, MD, medical director of informatics at Radiology Associates of North Texas, recently discussed how technology from Viz.ai is transforming his radiology practice, enhancing efficiency, and ultimately benefiting patient outcomes. 

GE Preview Image

Unifying IT to Improve Data Access, Physician Efficiency and KPI-driven Performance

Sponsored by GE Healthcare

Listen in to this discussion on enhancing efficiency for cardiologists and care teams with an integrated imaging and patient data strategy. Enterprise imaging simplifies IT by consolidating multi-ology images with patient data and providing a single view of all patient information.